中国医药
(600056)
| 流通市值：178.10亿 | | | 总市值：178.16亿 |
| 流通股本：14.95亿 | | | 总股本：14.96亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,706,629,673.57 | 3,209,712,856.96 | 2,630,887,358.28 | 3,867,266,395 |
| 衍生金融资产 | - | 0 | 665,447.5 | 1,108,515.03 |
| 应收票据及应收账款 | 15,801,408,852.22 | 15,918,672,982.02 | 15,590,662,777.21 | 14,149,627,168.1 |
| 其中：应收票据 | 445,529,351.94 | 440,364,907.82 | 372,640,286.98 | 311,390,288.15 |
| 应收账款 | 15,355,879,500.28 | 15,478,308,074.2 | 15,218,022,490.23 | 13,838,236,879.95 |
| 应收款项融资 | 253,766,809.94 | 329,892,667.56 | 510,236,447.15 | 621,071,994.12 |
| 预付款项 | 1,105,934,342.75 | 1,047,389,809.2 | 1,062,136,791.42 | 848,060,991.35 |
| 其他应收款合计 | 1,748,660,144.59 | 1,737,993,667.91 | 1,786,243,603.79 | 1,744,789,310.92 |
| 存货 | 6,830,209,470.71 | 5,884,057,908.46 | 5,973,394,998.92 | 6,232,263,429.32 |
| 合同资产 | 29,309,592.85 | 25,852,052.78 | 26,422,715.43 | 29,853,036.43 |
| 一年内到期的非流动资产 | 53,405,277.74 | 53,405,277.74 | 78,290,534.19 | 105,326,671.4 |
| 其他流动资产 | 349,593,832.61 | 484,845,414.19 | 863,172,768.65 | 926,815,253.77 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 28,878,917,996.98 | 28,691,822,636.82 | 28,522,113,442.54 | 28,526,182,765.44 |
| 非流动资产: | | | | |
| 长期应收款 | 18,326,038.5 | 18,278,491.68 | 18,276,977.99 | 5,258,806.6 |
| 长期股权投资 | 2,684,276,717.03 | 2,672,276,717.03 | 2,660,032,764.68 | 2,649,127,464.68 |
| 其他权益工具投资 | 47,085,401.26 | 47,085,401.26 | 8,085,401.26 | 7,085,401.26 |
| 投资性房地产 | 88,082,460.82 | 87,802,317.23 | 86,594,330.48 | 89,833,334.57 |
| 固定资产 | 2,260,725,729.05 | 2,273,543,912.05 | 2,311,280,667.8 | 2,315,505,680.32 |
| 在建工程 | 236,704,579.8 | 202,971,372.24 | 178,771,721.12 | 196,022,948.23 |
| 使用权资产 | 293,569,750.42 | 311,127,532.55 | 341,262,795.45 | 365,649,405.69 |
| 无形资产 | 614,922,727.48 | 607,405,514.1 | 603,907,149.5 | 604,265,767.6 |
| 开发支出 | 530,291,755.8 | 488,112,428.14 | 460,085,213.84 | 388,837,786.7 |
| 商誉 | 1,123,822,084.62 | 1,123,822,084.62 | 1,123,822,084.62 | 1,123,822,084.62 |
| 长期待摊费用 | 156,051,716.46 | 151,580,366.78 | 154,080,571.28 | 157,738,119.09 |
| 递延所得税资产 | 675,571,807.74 | 670,708,563.35 | 666,113,885.54 | 663,498,704.85 |
| 其他非流动资产 | 269,527,854.39 | 272,858,712.3 | 290,650,313.81 | 317,083,952.63 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 8,998,958,623.37 | 8,927,573,413.33 | 8,902,963,877.37 | 8,883,729,456.84 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 37,877,876,620.35 | 37,619,396,050.15 | 37,425,077,319.91 | 37,409,912,222.28 |
| 流动负债: | | | | |
| 短期借款 | 3,584,066,818.33 | 3,315,455,015.06 | 2,891,853,936.41 | 2,250,022,660.6 |
| 应付票据及应付账款 | 10,443,355,990.58 | 9,793,053,959.74 | 9,742,922,016.88 | 9,893,893,013.48 |
| 其中：应付票据 | 1,263,266,418.7 | 1,219,357,238.64 | 1,322,163,164.41 | 1,336,587,899.56 |
| 应付账款 | 9,180,089,571.88 | 8,573,696,721.1 | 8,420,758,852.47 | 8,557,305,113.92 |
| 预收款项 | 6,358,640.72 | 3,973,089.51 | 5,524,872.71 | 5,654,870.1 |
| 合同负债 | 1,239,677,056.4 | 1,117,626,966.58 | 1,207,505,343.59 | 1,442,571,565.88 |
| 应付职工薪酬 | 258,201,322.96 | 245,429,893.35 | 265,114,588.12 | 376,618,717.22 |
| 应交税费 | 132,509,208.14 | 147,015,862.52 | 150,463,196.2 | 198,561,899.51 |
| 其他应付款合计 | 3,473,041,559.38 | 3,844,183,702.2 | 3,340,337,818.01 | 2,944,973,623.28 |
| 应付股利 | 19,508,671.31 | 141,792,194.89 | 5,277,829.97 | 5,277,829.97 |
| 一年内到期的非流动负债 | 550,173,018.41 | 592,831,742.09 | 677,276,186.18 | 601,996,729.63 |
| 其他流动负债 | 224,748,238.51 | 233,229,961.7 | 240,660,349.59 | 289,008,654.78 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 19,912,131,853.43 | 19,292,800,192.75 | 18,521,658,307.69 | 18,003,301,734.48 |
| 非流动负债: | | | | |
| 长期借款 | 1,643,856,829.3 | 1,928,356,829.3 | 1,928,356,829.3 | 2,508,366,829.3 |
| 租赁负债 | 235,187,992.1 | 252,951,117.88 | 279,510,897.2 | 260,037,005.68 |
| 长期应付款 | 1,899,394,225.31 | 1,947,288,795.31 | 1,961,522,046.8 | 1,979,825,336.8 |
| 长期应付职工薪酬 | 16,625,799.57 | 16,625,799.57 | 16,625,799.57 | 16,625,799.57 |
| 预计负债 | 1,672,226.55 | 131,496,414.16 | 543,571,644.78 | 673,635,747.97 |
| 递延收益 | 66,569,124.24 | 66,996,962.36 | 67,912,710.57 | 68,864,691.71 |
| 递延所得税负债 | 13,684,654.69 | 14,134,215.64 | 14,051,337 | 11,629,632.47 |
| 其他非流动负债 | - | 0 | - | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 3,876,990,851.76 | 4,357,850,134.22 | 4,811,551,265.22 | 5,518,985,043.5 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 23,789,122,705.19 | 23,650,650,326.97 | 23,333,209,572.91 | 23,522,286,777.98 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,495,879,748 | 1,495,879,748 | 1,495,879,748 | 1,495,879,748 |
| 资本公积 | 2,012,303,239.72 | 2,012,303,239.72 | 2,012,303,239.72 | 2,012,303,239.72 |
| 其他综合收益 | -2,069,120.46 | 18,981.04 | 2,837,622.34 | 1,476,139.92 |
| 盈余公积 | 603,726,551.38 | 603,726,551.38 | 603,726,551.38 | 603,726,551.38 |
| 未分配利润 | 7,547,371,404.8 | 7,457,862,542.89 | 7,592,762,420.42 | 7,447,162,468.43 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 11,657,211,823.44 | 11,569,791,063.03 | 11,707,509,581.86 | 11,560,548,147.45 |
| 少数股东权益 | 2,431,542,091.72 | 2,398,954,660.15 | 2,384,358,165.14 | 2,327,077,296.85 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 14,088,753,915.16 | 13,968,745,723.18 | 14,091,867,747 | 13,887,625,444.3 |
| 负债和股东权益合计 | 37,877,876,620.35 | 37,619,396,050.15 | 37,425,077,319.91 | 37,409,912,222.28 |
| 公告日期 | 2024-10-26 | 2024-08-21 | 2024-04-30 | 2024-04-27 |
| 审计意见(境内) | | | | 标准无保留意见 |